They down regulate both the CD4 receptor and the CXCR4 and CCR5 coreceptors, thus preventing de novo HIV-1 infection in susceptible cells [180,181,182], but also inhibit HIV-1 de novo infection in a receptor dependent and independent fashion in monocytic and lymphocytic infection models [177]. This evidence concerns the gene CCR5 and HIV-1 infection.